Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tikhonov, I.
Right arrow Articles by Chyzh, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tikhonov, I.
Right arrow Articles by Chyzh, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 12, Issue 12 2557-2561, Copyright © 1997 by Oxford University Press


ORIGINAL ARTICLES

A study of interleukin-8 and defensins in urine and plasma of patients with pyelonephritis and glomerulonephritis

I Tikhonov, A Rebenok and A Chyzh
Institute of Hematology and Blood Transfusion, Laboratory of Cellular and Molecular Immunology, 223059 Minsk, Byelarus; Institute of Physician's Postgraduate Education, Minsk, Byelarus; Corresponding author

Background: Interleukin-8 (IL-) plays a crucial role in the recruitment and activation of polymorphonucleated leukocytes (PMN) in the site of inflammation. Defensins are specific cationic proteins from azurophil PMN granules which exert antimicrobial, cytotoxic and proinflammatory activities. Methods: Urine and plasma levels of IL-8 and defensins were studied using specific enzyme-linked imunosorbent assays. IL-8 was determined in 107 patients, including 45 with chronic glomerulonephritis (GN) and 62 with chronic pyelonephritis (PN). Urine and plasma levels of defensins were studied simultaneously in 29 patients with GN and 29 with PN. None of the patients examined showed any evidence of renal insufficiency. A group of 24 healthy volunteers was used as a control. Results: Urinary IL-8 was significantly increased in all groups of patients comparing with healthy control (<30 pg/ml). The level of IL-8 in the urine of patients with PN (477±114 pg/ml, mean±SEM) was significantly (P <0.001) higher than in patients with GN (53±7 pg/ml). The concentration of defensins in urine of patients with GN was slightly increased in comparison with the normal level (21±3.5 ng/ml versus 15.7±2.8 ng/ml). Urinary defensins were significantly elevated in patients with PN (134±118 ng/ml, P<0.001),and were significantly higher than in the GN group (P <0.001). A close correlation was observed between IL-8 and defensin concentrations in urine (r=0.62), and between the urinary leukocyte count and IL-8 level (r=0.72). The highest levels of IL-8 were observed in patients with PN, associated with nephrolithiasis 914 patients, 822±219 pg/ml versus 367±72 pg/ml in patients with PN alone, P <0.05). IL-8 and defensin levels increased in older patients with PN, but not in older patients with GN. Conclusions: The levels of IL-8 and defensins in urine were 7-10-fold higher in patients with PN than in patients with GN. Thus, there is a significant difference in IL-8 production between septic and aseptic chronic inflammatory processes in kidney. It is possible to speculate that the timing and progression of kidney inflammation is mediated by an IL-8 dependent mechanism at least in the case of PN. Key words: interleukin-8; defensins; inflammation; pyelonephritis; glomerulonephritis
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
A S Taha, V Grant, and R W Kelly
Urinalysis for interleukin-8 in the non-invasive diagnosis of acute and chronic inflammatory diseases
Postgrad. Med. J., March 1, 2003; 79(929): 159 - 163.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.